Paid Clinical Trials in Fort Myers, FL
As of August 2026, 171 paid clinical trials are recruiting in Fort Myers, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fort Myers offers studies at sites including Golisano Children's Hospital of Southwest Florida for conditions such as Non-Small Cell Lung Cancer, Endometrial Cancer, Malignant Solid Neoplasm, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Fort Myers
Trials by drug in Fort Myers
Filter results
Newly added in Fort Myers
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Assessing Tissue Response to High-Velocity Thrust Manipulations on Capsule Length and Stiffness at the C5-C6 Facet Joint Capsule
164 clinical trials
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Top Research Study Locations in Fort Myers
Researchers run research studies in Fort Myers, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Golisano Children's Hospital of Southwest Florida | Acute Myeloid Leukemia, Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia | 31 |
| Florida Cancer Specialists - South | Carcinoma, Non-Small-Cell Lung, Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung (NSCLC) | 12 |
| Florida Cancer Specialists | Carcinoma, Non-Small-Cell Lung, Acinar Cell Carcinoma, Advanced CCNE1-amplified Solid Tumors | 10 |
| Regional Cancer Center-Lee Memorial Health System | Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia | 10 |
| Southwest General Healthcare Center | Type 2 Diabetes, Hypercholesterolemia, Metabolic Dysfunction-Associated Steatotic Liver Disease | 6 |
| Florida Cancer Specialists & Research Institute | Essential Thrombocythemia, Leukemia, Myeloid, Acute, Metastatic Castration-resistant Prostate Neoplasms | 5 |
| Neuropsychiatric Research Center of Southwest Florida | Alzheimer Disease, AD, Alzheimer Disease Due to P. Gingivalis | 4 |
| Covenant Metabolic Specialists, LLC - Fort Myers | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 3 |
| Florida Cancer Specialists South | Colorectal Neoplasms, Squamous Cell Carcinoma of Head and Neck | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Florida Cancer Specialists & Research Institute, LLC | Carcinoma, Non-Small Cell Lung, Cutaneous Melanoma, Cutaneous Squamous Cell Cancer | 2 |
| Florida Cancer Specialists - SOUTH - SCRI - PPDS | Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer | 2 |
| Florida Gulf Coast University Marieb Hall 101 | Head and Neck, Headache, Neck Pain Musculoskeletal | 2 |
| Florida Gynecologic Oncology | HPV Infection, Pre-Cancerous Dysplasia, CIN 2/3 | 2 |
| Florida Oncology & Hematology | Breast Neoplasms, CRC (Colorectal Cancer), Neoplasm Metastasis | 2 |
| Florida Oncology and Hematology | CLL, Chronic Lymphocytic Leukemia, Extensive Stage Small-cell Lung Cancer | 2 |
| GSK Investigational Site | Multiple Myeloma, Non-alcoholic Fatty Liver Disease | 2 |
| Gulfcoast Clinical Research Center | Major Depressive Disorder | 2 |
| HealthPark Medical Center | Mitral Valve Disease, Mitral Valve Regurgitation | 2 |
| US Renal Care - Fort Myers South | Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis, Chronic Kidney Disease, Receiving Dialysis | 2 |
| Alliance for Multispeciality Research - Fort Myers | Hidradenitis Suppurativa, Dermatitis Atopic | 2 |
| Covenant Metabolic Specialists, LLC | Primary Biliary Cholangitis, Crohn's Disease | 2 |
| Gulf Coast Clinical Research Center | Migraine | 2 |
| 544 | Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer | 1 |
Active & Upcoming Studies in Fort Myers (2026)
Recruiting trials in Fort Myers grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (76 active studies)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
- A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer · Phase 3 · BioNTech SE
Diabetes & metabolic (12 active studies)
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy · Phase 2 · Biomea Fusion Inc.
Neurology & pain (6 active studies)
- Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease · Phase 2 · Lighthouse Pharmaceuticals, Inc.
- Assessing Tissue Response to High-Velocity Thrust Manipulations on Capsule Length and Stiffness at the C5-C6 Facet Joint Capsule · Florida Gulf Coast University
Cardiovascular (5 active studies)
- Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension · Phase 2 · Vanda Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Eye & vision (4 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
Vaccines (2 active studies)
- Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults · Phase 1 · Clover Biopharmaceuticals USA, LLC
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
Pediatric (2 active studies)
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
- A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer · Phase 2 · Eli Lilly and Company
Common conditions studied in Fort Myers
- Non-Small Cell Lung Cancer (7 active studies)
- Endometrial Cancer (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
- Chronic Lymphocytic Leukemia (4 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
Leading research sponsors in Fort Myers
- Children's Oncology Group
- National Cancer Institute (NCI)
- Merck Sharp & Dohme LLC
- Eli Lilly and Company
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Fort Myers?
There are approximately 171 recruiting clinical trials in Fort Myers, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fort Myers pay participants?
Most recruiting trials in Fort Myers compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fort Myers?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fort Myers?
The most common conditions under active study in Fort Myers include Non-Small Cell Lung Cancer (7), Endometrial Cancer (5), Malignant Solid Neoplasm (5), Acute Myeloid Leukemia (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fort Myers?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fort Myers on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fort Myers?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fort Myers?
Recruiting research sites in Fort Myers include Golisano Children's Hospital of Southwest Florida, Florida Cancer Specialists - South, Florida Cancer Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fort Myers right now?
The largest active categories in Fort Myers are Cancer & tumors (76), Diabetes & metabolic (12), Neurology & pain (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.